Who can use Mylotarg(Gemtuzumab ozogamicin)?

Gemtuzumab ozogamicin is a CD33-directed antibody and cytotoxic drug conjugate indicated for:

1. Treatment of newly diagnosed CD33-positive acute myeloid leukemia (AML) in adults and children aged 1 month and above.

2. Treatment of relapsed or refractory CD33-positive acute myeloid leukemia (AML) in adults and children aged 2 years and above.

Gemtuzumab ozogamicin(Mylotarg)

Gemtuzumab ozogamicin is a CD33-directed antibody and cytotoxic drug conjugate indicated for: 1. Treatment of newly diagnosed CD33-positive acute myeloid leukemia (AML) in adults...

CATEGORY NAVIGATION

What Are the Indications for Gemtuzumab (Mylotarg)?

Gemtuzumab (Mylotarg) is an innovative CD33-directed antibody-drug conjugate (ADC) that plays a crucial role in the...

Tuesday, December 9th, 2025, 11:58

What is Inotuzumab ozogamicin (Besponsa)?

Inotuzumab ozogamicin (Besponsa) is an antibody-drug conjugate (ADC) targeting CD22. It achieves targeted...

Thursday, November 27th, 2025, 09:11

Gemtuzumab instructions, medical insurance, price, efficacy, adverse reactions

Mylotarg is a monoclonal antibody drug targeting CD33 antigen, developed and produced by Pfizer in the United...

Tuesday, July 8th, 2025, 16:21

Departments

Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology

Contact Medical Consultant

Global Drug Search

Clinical recruitment

overseas medical treatment

Remote consultation

Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.

Click to submit medical consultant

haiousales@gmail.com

Welcome To Consult